Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Codatta (XNY) Price & Performance

InjectiveTrade
CodattaTrade

Price performance (Past 24H)

Key statistics

Injective vs Codatta — how do they compare? Injective trades at Rp92,698 (market cap Rp9,26T, Rp1,75T 24h volume), while Codatta trades at Rp108.05 (market cap Rp267,63M, Rp60,3M 24h volume). The key difference: Injective is far larger — about 34600× Codatta's market cap, and Codatta's supply is capped (2,5B / 10B XNY (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Codatta for 3 Days on average.

INJXNY
Market Cap
Rp9,26TRp267,63M
Volume (24h)
Rp1,75TRp60,3M
Circulating Supply
100M INJ2,5B / 10B XNY (25%)
Typical Hold Time
36 Days3 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Codatta

Codatta (XNY) is trading at Rp107.2027 with a market cap of Rp266.4M, showing a bearish technical signal as it hovers near resistance at Rp108. The asset has a circulating supply of 2.5M tokens (25% of max supply) and a short average hold time of 3 days, indicating high trader turnover. No major protocol updates or ecosystem developments were noted in recent data.

Overall outlook remains cautious due to weak technical momentum and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, while risks involve low liquidity, high volatility, and minimal institutional interest. Investors should monitor for any network activity changes or exchange developments.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
XNY
84% Buy16% Sell
Avg holding period · 3 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Codatta

Codatta is a decentralized infrastructure protocol that converts human and AI-generated knowledge into ownable, royalty-generating digital assets. It enables contributors to fractionalize data and earn ongoing revenue streams. Operating across BNB Chain, Ethereum, and Solana, Codatta provides provenance tracking, licensing, and automated payouts as a plug-and-play backend for AI and DeSci ecosystems.

Read more on XNY